home / stock / zyxi / zyxi news


ZYXI News and Press, Zynex Inc. From 03/23/22

Stock Information

Company Name: Zynex Inc.
Stock Symbol: ZYXI
Market: NASDAQ
Website: zynex.com

Menu

ZYXI ZYXI Quote ZYXI Short ZYXI News ZYXI Articles ZYXI Message Board
Get ZYXI Alerts

News, Short Squeeze, Breakout and More Instantly...

ZYXI - Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado

Zynex Recognized as Fourth Largest Biotechnology/Bioscience Company in Colorado PR Newswire ENGLEWOOD, Colo. , March 23, 2022 /PRNewswire/ -- Zynex, Inc . ( Nasdaq: ZYXI ) an innovative medical technology company specializing in the manufacture and sa...

ZYXI - Medical Device Stocks in Sweet Spot as Correction Creates Historic Opportunity (MDT, EMED, ZYXI, ECOR, NVCR, TIVC, ZBH, ISRG)

One positive spin we can put on the “great growth stock bear market of 2022” – which, let’s face it, is what we are dealing with so far this year – is the value being created for future portfolio returns. We have seen indiscriminate selling in many high-grow...

ZYXI - Catalyst watch for next week: GE Investor Day, Apple event and AT&T spotlight

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

ZYXI - Zynex, Inc's. (ZYXI) CEO Thomas Sandgaard on Q4 2021 Results - Earnings Call Transcript

Zynex, Inc. (ZYXI) Q4 2021 Earnings Conference Call February 24, 2022, 04:15 PM ET Company Participants Thomas Sandgaard – Chairman, President and CEO Dan Moorhead - CFO Anna Lucsok - Chief Operating Officer Donald Gregg - Vice President, Monitoring Division Conference Call Participant...

ZYXI - Zynex GAAP EPS of $0.23 beats by $0.04, revenue of $40.37M misses by $0.95M

Zynex press release (NASDAQ:ZYXI): Q4 GAAP EPS of $0.23 beats by $0.04. Revenue of $40.37M (+57.7% Y/Y) misses by $0.95M. Q1 revenue to be in the range of $29M-$32M vs. consensus of $35.73M. FY2022 revenue is estimated in the range of $150M-$170M vs. consensus of $171.54M. For further detai...

ZYXI - Zynex Announces 2021 Fourth Quarter and Full Year Earnings

Zynex Announces 2021 Fourth Quarter and Full Year Earnings PR Newswire ENGLEWOOD, Colo. , Feb. 24, 2022 /PRNewswire/ -- Zynex, Inc . (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical ...

ZYXI - Creative Medical, HOOKIPA top healthcare gainers; Baudax Bio Nuvectis lead losers pack

Gainers: Creative Medical Technology (NASDAQ:CELZ) +33%. HOOKIPA Pharma (NASDAQ:HOOK) +18%. Zynex ZYXI +17%. AMN Healthcare Services (NYSE:AMN) +15%. ShockWave Medical (NASDAQ:SWAV) +10%. Losers: Baudax Bio (NASDAQ:BXRX) -11%. Nuvectis Pharma (NASDAQ:NVCT)&#...

ZYXI - Zynex plays down impact of loss of UnitedHealth contract

Zynex (NASDAQ:ZYXI) rules out any material impact to the company topline after United Health Care dropped its coverage for the pain-related healthcare equipment company. In response to what it called a “short report,” Zynex (ZYXI) CEO Thomas Sandgaard said on Friday: "We do not ...

ZYXI - Zynex Anticipates No Material Change in Revenue from Switch in United Health Care Prescription Coverage

Zynex Anticipates No Material Change in Revenue from Switch in United Health Care Prescription Coverage PR Newswire ENGLEWOOD, Colo. , Feb. 18, 2022 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manu...

ZYXI - Zynex, down 19%, hits 52-week low as it is dropped from UnitedHealth network

Zynex (ZYXI -19.4%) stock is down significantly in afternoon trading and hit a 52-week low of $5.62 earlier. Year to date through yesterday, shares are down ~61%. Today's plunge may be related to UnitedHealth Group (UNH -0.9%) removing Zynex from its network as of Feb. 15. Seeking A...

Previous 10 Next 10